C
Chiyomi Ito
Researcher at Kobe University
Publications - 12
Citations - 1654
Chiyomi Ito is an academic researcher from Kobe University. The author has contributed to research in topics: Fukuyama congenital muscular dystrophy & Muscular dystrophy. The author has an hindex of 10, co-authored 11 publications receiving 1526 citations. Previous affiliations of Chiyomi Ito include Osaka University.
Papers
More filters
Journal ArticleDOI
Genome-wide association study identifies common variants at four loci as genetic risk factors for Parkinson's disease
Wataru Satake,Yuko Nakabayashi,Yuko Nakabayashi,Ikuko Mizuta,Ikuko Mizuta,Yushi Hirota,Yushi Hirota,Chiyomi Ito,Chiyomi Ito,Michiaki Kubo,Takahisa Kawaguchi,Tatsuhiko Tsunoda,Masahiko Watanabe,Atsushi Takeda,Hiroyuki Tomiyama,Kenji Nakashima,Kazuko Hasegawa,Fumiya Obata,Takeo Yoshikawa,Hideshi Kawakami,Saburo Sakoda,Mitsutoshi Yamamoto,Nobutaka Hattori,Miho Murata,Yusuke Nakamura,Tatsushi Toda,Tatsushi Toda +26 more
TL;DR: The results identify two new PD susceptibility loci, show involvement of autosomal dominant parkinsonism loci in typical PD and suggest that population differences contribute to genetic heterogeneity in PD.
Journal ArticleDOI
Multiple candidate gene analysis identifies α-synuclein as a susceptibility gene for sporadic Parkinson's disease
Ikuko Mizuta,Wataru Satake,Yuko Nakabayashi,Chiyomi Ito,Satoko Suzuki,Yoshio Momose,Yoshitaka Nagai,Akira Oka,Hidetoshi Inoko,Jiro Fukae,Yuko Saito,Motoji Sawabe,Shigeo Murayama,Mitsutoshi Yamamoto,Nobutaka Hattori,Miho Murata,Tatsushi Toda +16 more
TL;DR: Findings establish SNCA as a definite susceptibility gene for sporadic PD, a major component of Lewy bodies, the pathological hallmark of PD.
Journal ArticleDOI
Impaired viability of muscle precursor cells in muscular dystrophy with glycosylation defects and amelioration of its severe phenotype by limited gene expression
Motoi Kanagawa,Chih Chieh Yu,Chiyomi Ito,So-ichiro Fukada,Masako Hozoji-Inada,Tomoko Chiyo,Atsushi Kuga,Megumi Matsuo,Kanoko Sato,Masahiko Yamaguchi,Takahito Ito,Yoshihisa Ohtsuka,Yuki Katanosaka,Yuko Miyagoe-Suzuki,Keiji Naruse,Kazuhiro Kobayashi,Takashi Okada,Shin'ichi Takeda,Tatsushi Toda +18 more
TL;DR: The findings indicated that fukutin-deficient dystroglycanopathy is a regeneration-defective disorder, and gene therapy is a feasible treatment for the wide range of dyStrogly canopathy even after disease progression.
Journal ArticleDOI
Hsp40 Gene Therapy Exerts Therapeutic Effects on Polyglutamine Disease Mice via a Non-Cell Autonomous Mechanism
H. Akiko Popiel,Toshihide Takeuchi,Hiromi Fujita,Kazuhiro Yamamoto,Chiyomi Ito,Hiroshi Yamane,Shin-ichi Muramatsu,Tatsushi Toda,Keiji Wada,Yoshitaka Nagai +9 more
TL;DR: The therapeutic effect of Hsp40 gene therapy on the neurological phenotypes of polyQ disease mice is demonstrated for the first time and even in virus non-infected cells that AAV5-Hsp40 appreciably suppresses inclusion body formation, suggesting a non-cell autonomous therapeutic effect.
Journal ArticleDOI
Partial tandem duplication of GRIA3 in a male with mental retardation.
Tomohiro Chiyonobu,Shin Hayashi,Kazuhiro Kobayashi,Masafumi Morimoto,Yuri Miyanomae,Akira Nishimura,Akemi Nishimoto,Chiyomi Ito,Issei Imoto,Tohru Sugimoto,Zhengping Jia,Johji Inazawa,Tatsushi Toda +12 more
TL;DR: The idea that GRIA3 is a candidate gene for X‐linked MR and that severely reducedGRIA3 expression results in MR is strengthened.